Butchko Julia G. 4
4 · Immunovant, Inc. · Filed Apr 4, 2024
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Butchko Julia G.
Chief Dev. & Tech. Officer
Transactions
- Award
Common Stock
2024-04-02+54,978→ 462,795 total - Award
Stock Option (right to buy)
2024-04-02+68,723→ 68,723 totalExercise: $30.78Exp: 2034-04-02→ Common Stock (68,723 underlying)
Footnotes (2)
- [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. The RSUs will vest as to 25% of the units on April 2, 2025, and the remainder will vest in substantially equal installments on a quarterly basis over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.
- [F2]The shares underlying the options will vest as to 25% of the shares on April 2, 2025 and the remainder will vest in 36 substantially equal monthly installments over three years thereafter, subject to the Reporting Person's continuous service to the Issuer as of such date.